Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 22 studies | 90% ± 13% | |
lung | 19 studies | 77% ± 21% | |
intestine | 13 studies | 74% ± 26% | |
brain | 13 studies | 42% ± 22% | |
eye | 11 studies | 51% ± 23% | |
kidney | 9 studies | 78% ± 19% | |
bone marrow | 6 studies | 84% ± 13% | |
liver | 6 studies | 75% ± 11% | |
lymph node | 5 studies | 95% ± 2% | |
uterus | 5 studies | 88% ± 16% | |
prostate | 5 studies | 72% ± 33% | |
pancreas | 4 studies | 77% ± 24% | |
placenta | 4 studies | 84% ± 25% | |
adipose | 4 studies | 52% ± 26% | |
esophagus | 4 studies | 70% ± 25% | |
breast | 4 studies | 93% ± 4% | |
heart | 3 studies | 44% ± 16% | |
adrenal gland | 3 studies | 81% ± 16% | |
skin | 3 studies | 77% ± 22% | |
stomach | 3 studies | 56% ± 30% | |
thymus | 3 studies | 84% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 43940.72 | 1445 / 1445 | 100% | 476.90 | 183 / 183 |
ovary | 100% | 102175.59 | 180 / 180 | 100% | 957.57 | 430 / 430 |
pancreas | 100% | 54640.28 | 328 / 328 | 100% | 552.10 | 178 / 178 |
skin | 100% | 74867.44 | 1809 / 1809 | 100% | 811.88 | 472 / 472 |
thymus | 100% | 40543.25 | 653 / 653 | 100% | 760.30 | 605 / 605 |
uterus | 100% | 57013.82 | 170 / 170 | 100% | 647.43 | 459 / 459 |
prostate | 100% | 49464.03 | 245 / 245 | 100% | 1042.52 | 501 / 502 |
stomach | 100% | 36506.36 | 359 / 359 | 100% | 686.53 | 285 / 286 |
breast | 100% | 58226.22 | 459 / 459 | 100% | 679.52 | 1114 / 1118 |
intestine | 100% | 42705.46 | 966 / 966 | 100% | 837.04 | 525 / 527 |
lung | 100% | 41246.10 | 577 / 578 | 100% | 550.26 | 1152 / 1155 |
kidney | 100% | 39367.64 | 89 / 89 | 100% | 757.69 | 897 / 901 |
bladder | 100% | 46069.19 | 21 / 21 | 99% | 654.65 | 500 / 504 |
adrenal gland | 100% | 43666.10 | 258 / 258 | 99% | 432.05 | 228 / 230 |
liver | 100% | 20902.07 | 225 / 226 | 100% | 423.79 | 404 / 406 |
brain | 96% | 14827.75 | 2534 / 2642 | 99% | 496.06 | 700 / 705 |
adipose | 100% | 54015.39 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 1684.09 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 1270.53 | 29 / 29 |
spleen | 100% | 46541.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 667.40 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 277.45 | 1 / 1 |
blood vessel | 100% | 38583.47 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 37936.68 | 802 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 52034.76 | 918 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 23949.80 | 843 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0051901 | Biological process | positive regulation of mitochondrial depolarization |
GO_2000543 | Biological process | positive regulation of gastrulation |
GO_2000114 | Biological process | regulation of establishment of cell polarity |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0042998 | Biological process | positive regulation of Golgi to plasma membrane protein transport |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0032880 | Biological process | regulation of protein localization |
GO_1900102 | Biological process | negative regulation of endoplasmic reticulum unfolded protein response |
GO_2001244 | Biological process | positive regulation of intrinsic apoptotic signaling pathway |
GO_0045879 | Biological process | negative regulation of smoothened signaling pathway |
GO_0106070 | Biological process | regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0007369 | Biological process | gastrulation |
GO_0071363 | Biological process | cellular response to growth factor stimulus |
GO_0072344 | Biological process | rescue of stalled ribosome |
GO_0051302 | Biological process | regulation of cell division |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_1903751 | Biological process | negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide |
GO_0030178 | Biological process | negative regulation of Wnt signaling pathway |
GO_0050765 | Biological process | negative regulation of phagocytosis |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0043473 | Biological process | pigmentation |
GO_0006915 | Biological process | apoptotic process |
GO_0033137 | Biological process | negative regulation of peptidyl-serine phosphorylation |
GO_0032091 | Biological process | negative regulation of protein binding |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0048511 | Biological process | rhythmic process |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0017148 | Biological process | negative regulation of translation |
GO_0002181 | Biological process | cytoplasmic translation |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0030496 | Cellular component | midbody |
GO_0022627 | Cellular component | cytosolic small ribosomal subunit |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0043204 | Cellular component | perikaryon |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030425 | Cellular component | dendrite |
GO_0005829 | Cellular component | cytosol |
GO_0015935 | Cellular component | small ribosomal subunit |
GO_0001891 | Cellular component | phagocytic cup |
GO_0005737 | Cellular component | cytoplasm |
GO_1990630 | Cellular component | IRE1-RACK1-PP2A complex |
GO_0005634 | Cellular component | nucleus |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0008047 | Molecular function | enzyme activator activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0008200 | Molecular function | ion channel inhibitor activity |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0051434 | Molecular function | BH3 domain binding |
GO_0019903 | Molecular function | protein phosphatase binding |
GO_0043022 | Molecular function | ribosome binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0045182 | Molecular function | translation regulator activity |
GO_0008656 | Molecular function | cysteine-type endopeptidase activator activity involved in apoptotic process |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0042169 | Molecular function | SH2 domain binding |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0030292 | Molecular function | protein tyrosine kinase inhibitor activity |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
GO_0030332 | Molecular function | cyclin binding |
Gene name | RACK1 |
Protein name | Small ribosomal subunit protein RACK1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Receptor of activated protein C kinase 1) [Cleaved into: Small ribosomal subunit protein RACK1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed) (Receptor of activated protein C kinase 1, N-terminally processed)] Receptor for activated C kinase 1 Small ribosomal subunit protein RACK1 (Guanine nucleotide-binding protein subunit beta-2-like 1) |
Synonyms | PIG21 GNB2L1 HLC7 |
Description | FUNCTION: Scaffolding protein involved in the recruitment, assembly and/or regulation of a variety of signaling molecules. Interacts with a wide variety of proteins and plays a role in many cellular processes. Component of the 40S ribosomal subunit involved in translational repression . Involved in the initiation of the ribosome quality control (RQC), a pathway that takes place when a ribosome has stalled during translation, by promoting ubiquitination of a subset of 40S ribosomal subunits . Binds to and stabilizes activated protein kinase C (PKC), increasing PKC-mediated phosphorylation. May recruit activated PKC to the ribosome, leading to phosphorylation of EIF6. Inhibits the activity of SRC kinases including SRC, LCK and YES1. Inhibits cell growth by prolonging the G0/G1 phase of the cell cycle. Enhances phosphorylation of BMAL1 by PRKCA and inhibits transcriptional activity of the BMAL1-CLOCK heterodimer. Facilitates ligand-independent nuclear translocation of AR following PKC activation, represses AR transactivation activity and is required for phosphorylation of AR by SRC. Modulates IGF1R-dependent integrin signaling and promotes cell spreading and contact with the extracellular matrix. Involved in PKC-dependent translocation of ADAM12 to the cell membrane. Promotes the ubiquitination and proteasome-mediated degradation of proteins such as CLEC1B and HIF1A. Required for VANGL2 membrane localization, inhibits Wnt signaling, and regulates cellular polarization and oriented cell division during gastrulation. Required for PTK2/FAK1 phosphorylation and dephosphorylation. Regulates internalization of the muscarinic receptor CHRM2. Promotes apoptosis by increasing oligomerization of BAX and disrupting the interaction of BAX with the anti-apoptotic factor BCL2L. Inhibits TRPM6 channel activity. Regulates cell surface expression of some GPCRs such as TBXA2R. Plays a role in regulation of FLT1-mediated cell migration. Involved in the transport of ABCB4 from the Golgi to the apical bile canalicular membrane . Promotes migration of breast carcinoma cells by binding to and activating RHOA . Acts as an adapter for the dephosphorylation and inactivation of AKT1 by promoting recruitment of PP2A phosphatase to AKT1 (By similarity). .; FUNCTION: (Microbial infection) Binds to Y.pseudotuberculosis yopK which leads to inhibition of phagocytosis and survival of bacteria following infection of host cells. .; FUNCTION: (Microbial infection) Enhances phosphorylation of HIV-1 Nef by PKCs. .; FUNCTION: (Microbial infection) In case of poxvirus infection, remodels the ribosomes so that they become optimal for the viral mRNAs (containing poly-A leaders) translation but not for host mRNAs. .; FUNCTION: (Microbial infection) Contributes to the cap-independent internal ribosome entry site (IRES)-mediated translation by some RNA viruses. . |
Accessions | J3KPE3 ENST00000514455.5 D6RHH4 D6RHJ5 ENST00000502844.5 ENST00000503494.5 ENST00000376817.8 H0YAM7 H0YAF8 I3QNU9 ENST00000512968.5 D6RFZ9 ENST00000502905.5 H0Y9P0 ENST00000507756.5 H0Y8W2 D6RBD0 D6R909 D6RFX4 ENST00000512805.6 H0Y8R5 D6R9L0 ENST00000511900.5 ENST00000504325.5 E9PD14 D6RDI0 D6REE5 ENST00000506312.3 ENST00000626067.1 ENST00000509535.5 D6RF23 ENST00000507000.5 D6R9Z1 ENST00000504128.5 ENST00000511473.5 ENST00000508682.5 D6RAC2 ENST00000503081.1 ENST00000513027.3 D6RGK8 ENST00000511566.5 P63244 ENST00000509148.1 ENST00000504726.1 D6RAU2 ENST00000510199.5 |